Vertex expands beyond cystic fibrosis with CASGEVY Germany deal and WuXi pact
Vertex secured a Germany reimbursement agreement for CASGEVY and signed a WuXi Biologics pact for a preclinical autoimmune T-cell engager. The moves add to efforts to build revenue beyond cystic fibrosis.